203 related articles for article (PubMed ID: 16721364)
21. FGFR4 polymorphism, TP53 mutation, and their combinations are prognostic factors for oral squamous cell carcinoma.
Tanuma J; Izumo T; Hirano M; Oyazato Y; Hori F; Umemura E; Shisa H; Hiai H; Kitano M
Oncol Rep; 2010 Mar; 23(3):739-44. PubMed ID: 20127014
[TBL] [Abstract][Full Text] [Related]
22. Loss of heterozygosity and DNA methylation affect germline fibroblast growth factor receptor 4 polymorphism to direct allelic selection in breast cancer.
Zhu X; Zheng L; Asa SL; Ezzat S
Am J Pathol; 2010 Dec; 177(6):2860-9. PubMed ID: 21037081
[TBL] [Abstract][Full Text] [Related]
23. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
Morita K; Takano K; Yasufuku-Takano J; Yamada S; Teramoto A; Takei M; Osamura RY; Sano T; Fujita T
Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
[TBL] [Abstract][Full Text] [Related]
24. Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor.
Frullanti E; Berking C; Harbeck N; Jézéquel P; Haugen A; Mawrin C; Parise O; Sasaki H; Tsuchiya N; Dragani TA
Eur J Cancer Prev; 2011 Jul; 20(4):340-7. PubMed ID: 21412156
[TBL] [Abstract][Full Text] [Related]
25. FGFR4 Is a Potential Predictive Biomarker in Oral and Oropharyngeal Squamous Cell Carcinoma.
Koole K; van Kempen PM; van Bockel LW; Smets T; van der Klooster Z; Dutman AC; Peeters T; Koole R; van Diest P; van Es RJ; Willems SM
Pathobiology; 2015; 82(6):280-9. PubMed ID: 26551585
[TBL] [Abstract][Full Text] [Related]
26. Fibroblast growth factor receptor 4 polymorphism is associated with increased risk and poor prognosis of non-Hodgkin's lymphoma.
Gao L; Feng Z; Li Q; Li L; Chen L; Xiao T
Tumour Biol; 2014 Apr; 35(4):2997-3002. PubMed ID: 24248544
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of polymorphic alleles of FGF receptor 4 on colon cancer growth and metastasis.
Heinzle C; Gsur A; Hunjadi M; Erdem Z; Gauglhofer C; Stättner S; Karner J; Klimpfinger M; Wrba F; Reti A; Hegedus B; Baierl A; Grasl-Kraupp B; Holzmann K; Grusch M; Berger W; Marian B
Cancer Res; 2012 Nov; 72(22):5767-77. PubMed ID: 22971346
[TBL] [Abstract][Full Text] [Related]
28. FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls.
Xu B; Tong N; Chen SQ; Hua LX; Wang ZJ; Zhang ZD; Chen M
BMC Cancer; 2011 Feb; 11():84. PubMed ID: 21349172
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer.
Marmé F; Hielscher T; Hug S; Bondong S; Zeillinger R; Castillo-Tong DC; Sehouli J; Braicu I; Vergote I; Isabella C; Mahner S; Ferschke I; Rom J; Sohn C; Schneeweiss A; Altevogt P
Int J Cancer; 2012 Aug; 131(4):E586-91. PubMed ID: 22034009
[TBL] [Abstract][Full Text] [Related]
30. Association between fibroblast growth factor receptor 4 Gly388Arg polymorphism and ischaemic stroke.
Zhang HF; Zhao KJ; Yang PF; Fang YB; Zhang YH; Liu JM; Huang QH
J Int Med Res; 2012; 40(5):1708-14. PubMed ID: 23206452
[TBL] [Abstract][Full Text] [Related]
31. Analysis of a single nucleotide polymorphism in codon 388 of the FGFR4 gene in malignant gliomas.
Mawrin C; Kirches E; Diete S; Wiedemann FR; Schneider T; Firsching R; Kropf S; Bogerts B; Vorwerk CK; Krüger S; Dietzmann K
Cancer Lett; 2006 Aug; 239(2):239-45. PubMed ID: 16198476
[TBL] [Abstract][Full Text] [Related]
32. Upregulated ankyrin repeat-rich membrane spanning protein contributes to tumour progression in cutaneous melanoma.
Liao YH; Hsu SM; Yang HL; Tsai MS; Huang PH
Br J Cancer; 2011 Mar; 104(6):982-8. PubMed ID: 21343931
[TBL] [Abstract][Full Text] [Related]
33. Polymorphism of FGFR4 Gly388Arg does not confer an increased risk to breast cancer development.
Naidu R; Har YC; Taib NA
Oncol Res; 2009; 18(2-3):65-71. PubMed ID: 20066896
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Role of the FGFR4-388Arg Variant in Lung Squamous-Cell Carcinoma Patients With Lymph Node Involvement.
Quintanal-Villalonga Á; Carranza-Carranza A; Meléndez R; Ferrer I; Molina-Pinelo S; Paz-Ares L
Clin Lung Cancer; 2017 Nov; 18(6):667-674.e1. PubMed ID: 28583379
[TBL] [Abstract][Full Text] [Related]
35. Expression of milk fat globule epidermal growth factor-VIII may be an indicator of poor prognosis in malignant melanoma.
Oba J; Moroi Y; Nakahara T; Abe T; Hagihara A; Furue M
Br J Dermatol; 2011 Sep; 165(3):506-12. PubMed ID: 21574974
[TBL] [Abstract][Full Text] [Related]
36. Influence of the fibroblast growth factor receptor 4 expression and the G388R functional polymorphism on Cushing's disease outcome.
Brito LP; Lerário AM; Bronstein MD; Soares IC; Mendonca BB; Fragoso MC
J Clin Endocrinol Metab; 2010 Oct; 95(10):E271-9. PubMed ID: 20660043
[TBL] [Abstract][Full Text] [Related]
37. Prognostic implications of fibroblast growth factor receptor 4 polymorphisms in primary breast cancer.
Wei W; You Z; Sun S; Wang Y; Zhang X; Pang D; Jiang Y
Mol Carcinog; 2018 Aug; 57(8):988-996. PubMed ID: 29603419
[TBL] [Abstract][Full Text] [Related]
38. Histological expression of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in human primary melanoma.
Bron LP; Scolyer RA; Thompson JF; Hersey P
Pathology; 2004 Dec; 36(6):561-5. PubMed ID: 15841691
[TBL] [Abstract][Full Text] [Related]
39. Fibroblast growth factor receptor 4 polymorphisms and the prognosis of non-Hodgkin lymphoma.
Cha Z; Zang Y; Guo H; Gu H; Tu X; Song H; Qian B
Mol Biol Rep; 2014 Feb; 41(2):1165-70. PubMed ID: 24381107
[TBL] [Abstract][Full Text] [Related]
40. A single nucleotide change in the mouse genome accelerates breast cancer progression.
Seitzer N; Mayr T; Streit S; Ullrich A
Cancer Res; 2010 Jan; 70(2):802-12. PubMed ID: 20068154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]